
Zealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a ...
Company announcement – No. 4 / 2025 Zealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a future foundational therapy for people with overweight and obesity The companies will co-develop …